Chenhui Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chenhui Wang has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
Yan Zhang
Chongqing University
8 shared publicationsJian Guo
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, 55 Daxuecheng South Road, Shapingba, 401331 Chongqing, China
4 shared publicationsShuang Chen
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, 55 Daxuecheng South Road, Chongqing 401331, P. R. China
4 shared publicationsXiaohong Yang
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, 55 South Daxuecheng Road, Chongqing 401331, P. R. China
4 shared publications- Xuli Feng
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
4 shared publications - Yun He
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, P. R. China
4 shared publications
Latest Publications
- 13 September 2026
- Published by Springer Nature
- p. 1-43
Proteolysis Targeting Chimeras (PROTACs): Design and Mechanism
- 13 September 2026
- Published by Springer Nature
- p. 1-43
Proteolysis Targeting Chimeras (PROTACs): Design and Mechanism
- 7 May 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 266, 115791
Biomimetic nanozyme mitigates thermal damage in photothermal therapy by targeted disruption of tumor metabolism
- 7 May 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 266, 115791
Biomimetic nanozyme mitigates thermal damage in photothermal therapy by targeted disruption of tumor metabolism
- 14 April 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (21) , 11271-11279
Fibrin-targeted and pH-responsive liposomes for synergistic thrombolysis and thrombotic microenvironment reprogramming
A fibrin-targeting and pH-responsive drug delivery platform for thrombolysis and thrombus microenvironment reprogramming.
- 14 April 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (21) , 11271-11279
Fibrin-targeted and pH-responsive liposomes for synergistic thrombolysis and thrombotic microenvironment reprogramming
A fibrin-targeting and pH-responsive drug delivery platform for thrombolysis and thrombus microenvironment reprogramming.
- 21 December 2023
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (2) , 103864
Mapping the evolution of inhaled drug delivery research: Trends, collaborations, and emerging frontiers
- 21 December 2023
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (2) , 103864
Mapping the evolution of inhaled drug delivery research: Trends, collaborations, and emerging frontiers
- 6 December 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (2) , 903-912
Intracellular self-aggregation of biomimetic Fe3O4 nanoparticles for enhanced ferroptosis-inducing therapy of breast cancer
A supramolecular and cell membrane co-modified drug delivery system was constructed to enhance Fe3O4 and SAS synergistically induced ferroptosis anti-tumor therapy.
- 6 December 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (2) , 903-912
Intracellular self-aggregation of biomimetic Fe3O4 nanoparticles for enhanced ferroptosis-inducing therapy of breast cancer
A supramolecular and cell membrane co-modified drug delivery system was constructed to enhance Fe3O4 and SAS synergistically induced ferroptosis anti-tumor therapy.
- 15 August 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (73) , 10940-10943
Nucleus-selective self-augmenting cascade nanoassemblies for targeted synergistic photo-chemo therapy of tumors
The HPC-CAT/CL-Ap nanocomposite entered into tumor cell by endocytosis and quickly accumulate in the nucleus, thereby significantly inhibiting tumor growth and lung metastasis by self-augmenting cascade photo-chemo therapy.
- 15 August 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (73) , 10940-10943
Nucleus-selective self-augmenting cascade nanoassemblies for targeted synergistic photo-chemo therapy of tumors
The HPC-CAT/CL-Ap nanocomposite entered into tumor cell by endocytosis and quickly accumulate in the nucleus, thereby significantly inhibiting tumor growth and lung metastasis by self-augmenting cascade photo-chemo therapy.
- Open Access
- 28 July 2023
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 18 (4) , 100833
Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy
- 28 July 2023
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 18 (4) , 100833
Open AccessPulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy
- Open Access
- 7 March 2023
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 295, 122585
Novel fluorescent probe for sequential recognition of Zn2+ and pyrophosphate in aqueous based on aggregation-induced emission
- 7 March 2023
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 295, 122585
Open AccessNovel fluorescent probe for sequential recognition of Zn2+ and pyrophosphate in aqueous based on aggregation-induced emission
- 27 February 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (13) , 2937-2945
Calcium-peroxide-mediated cascades of oxygen production and glutathione consumption induced efficient photodynamic and photothermal synergistic therapy
The oxidative stress amplifier CaO2/ICG@ZIF-8 was constructed by loading CaO2 and ICG onto ZIF-8, achieving efficient photodynamic and photothermal synergistic therapy by CaO2-mediated cascades of oxygen production and glutathione consumption.
- 27 February 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (13) , 2937-2945
Calcium-peroxide-mediated cascades of oxygen production and glutathione consumption induced efficient photodynamic and photothermal synergistic therapy
The oxidative stress amplifier CaO2/ICG@ZIF-8 was constructed by loading CaO2 and ICG onto ZIF-8, achieving efficient photodynamic and photothermal synergistic therapy by CaO2-mediated cascades of oxygen production and glutathione consumption.
- Open Access
- 18 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 14294
Nanoemulsion Co-Loaded with XIAP siRNA and Gambogic Acid for Inhalation Therapy of Lung Cancer
Lung cancer is a leading cause of cancer mortality worldwide, with a 5-year survival rate of less than 20%. Gambogic acid (GA) is a naturally occurring and potent anticancer agent that destroys tumor cells through multiple mechanisms. According to the literature, one of the most potent inhibitors of caspases and apoptosis currently known is the X-linked Inhibitor of Apoptosis Protein (XIAP). It is highly expressed in various malignancies but has little or no expression in normal cells, making it an attractive target for cancer treatment. Here we report the development of a chitosan (CS)-based cationic nanoemulsion-based pulmonary delivery (p.d.) system for the co-delivery of antineoplastic drugs (GA) and anti-XIAP small interfering RNA (siRNA). The results showed that the chitosan-modified cationic nanoemulsions could effectively encapsulate gambogic acid as well as protect siRNA against degradation. The apoptosis analysis confirmed that the cationic nanoemulsions could induce more apoptosis in the A549 cell line. In addition, most drugs and siRNAs have a long residence time in the lungs through pulmonary delivery and show greater therapeutic effects compared to systemic administration. In summary, this work demonstrates the applicability of cationic nanoemulsions for combined cancer therapy and as a promising approach for the treatment of lung cancer.
- 18 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 14294
Open AccessNanoemulsion Co-Loaded with XIAP siRNA and Gambogic Acid for Inhalation Therapy of Lung Cancer
Lung cancer is a leading cause of cancer mortality worldwide, with a 5-year survival rate of less than 20%. Gambogic acid (GA) is a naturally occurring and potent anticancer agent that destroys tumor cells through multiple mechanisms. According to the literature, one of the most potent inhibitors of caspases and apoptosis currently known is the X-linked Inhibitor of Apoptosis Protein (XIAP). It is highly expressed in various malignancies but has little or no expression in normal cells, making it an attractive target for cancer treatment. Here we report the development of a chitosan (CS)-based cationic nanoemulsion-based pulmonary delivery (p.d.) system for the co-delivery of antineoplastic drugs (GA) and anti-XIAP small interfering RNA (siRNA). The results showed that the chitosan-modified cationic nanoemulsions could effectively encapsulate gambogic acid as well as protect siRNA against degradation. The apoptosis analysis confirmed that the cationic nanoemulsions could induce more apoptosis in the A549 cell line. In addition, most drugs and siRNAs have a long residence time in the lungs through pulmonary delivery and show greater therapeutic effects compared to systemic administration. In summary, this work demonstrates the applicability of cationic nanoemulsions for combined cancer therapy and as a promising approach for the treatment of lung cancer.